Connect your AI

Sanara MedTech Inc. SMTI Gross Profit

Gross Profit at other companies

Becton, Dickinson and CompanyBDX

$2.15B+15.7%

StrykerSYK

$3.81B+1.8%

IAR

Integra LifeSciencesIART

$216.98M+11.6%

SolventumSOLV

$1.1B-1.5%

Orthofix Medical Inc.OFIX

$139.55M+14.7%

ClearPoint NeuroCLPT

$7.76M+51.1%

Other financials

Income statement

Revenue$27.8M+18.6%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

$27.8Mtotal revenue−$1.9Mtotal cost of revenue=$25.87M

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sanara MedTech Inc.'s gross profit?: Sanara MedTech Inc. (SMTI) reported gross profit of $25.87M in Q1 2026.
How has Sanara MedTech Inc.'s gross profit changed year-over-year?: Sanara MedTech Inc.'s gross profit increased by 19.8% year-over-year, from $21.6M to $25.87M.
What is the long-term trend for Sanara MedTech Inc.'s gross profit?: Over 4 years (2021 to 2025), Sanara MedTech Inc.'s gross profit has grown at a 35.8% compound annual growth rate (CAGR), from $28.11M to $95.62M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.